Renal cell carcinoma other diagnostic studies: Difference between revisions
(Mahshid) |
|||
Line 10: | Line 10: | ||
{| border="1" style="border-collapse:collapse; text-align:left;" cellpadding="5" align="center" | {| border="1" style="border-collapse:collapse; text-align:left;" cellpadding="5" align="center" | ||
|+ '''''Histopathological Findings in Renal Cell Carcinoma<ref name="pmid16339096">{{cite journal| author=Cohen HT, McGovern FJ| title=Renal-cell carcinoma. |journal=N Engl J Med | year= 2005 | volume= 353 | issue= 23 | pages= 2477-90 | pmid=16339096 |doi=10.1056/NEJMra043172 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16339096 }} </ref><ref name="pmid19269025">{{cite journal| author=Rini BI, Campbell SC, Escudier B| title=Renal cell carcinoma. | journal=Lancet | year= 2009 | volume= 373 | issue= 9669 | pages= 1119-32 | pmid=19269025 | doi=10.1016/S0140-6736(09)60229-4 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19269025 }} </ref>''''' | |+ '''''Histopathological Findings in Renal Cell Carcinoma<ref name="pmid16339096">{{cite journal| author=Cohen HT, McGovern FJ| title=Renal-cell carcinoma. |journal=N Engl J Med | year= 2005 | volume= 353 | issue= 23 | pages= 2477-90 | pmid=16339096 |doi=10.1056/NEJMra043172 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16339096 }} </ref><ref name="pmid19269025">{{cite journal| author=Rini BI, Campbell SC, Escudier B| title=Renal cell carcinoma. | journal=Lancet | year= 2009 | volume= 373 | issue= 9669 | pages= 1119-32 | pmid=19269025 | doi=10.1016/S0140-6736(09)60229-4 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19269025 }} </ref>''''' | ||
| | | style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Type''' || style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Characteristic Features''' | ||
|- | |- | ||
| bgcolor="# | | bgcolor="#DCDCDC"|'''Conventional (Clear Cell)''' ||*Nests of tumor cells that are compacted near each other<br>*Clear cytoplasm<br>*Delicate vasculature that separates the cytoplasm<br>*Varying architectural patterns, such as solid, alveolar, or acinar | ||
|- | |- | ||
| bgcolor="# | | bgcolor="#DCDCDC"|'''Papillary''' || *Papillae, tubulopapillae, and tubules that are present in differing percentages<br>*Type I generally has papillae lined with only 1 layer of cancer cells, pale cytoplasm, and small oval nuclei<br>*Type II generally are more heterogeneous tumors that have pseudostratification with large, spherical nuclei and distinct nucleoli | ||
|- | |- | ||
| bgcolor="# | | bgcolor="#DCDCDC"|'''Chromophobe''' || *Large polygonal cells<br>*Finely reticulated cytoplasm that may be eosinophilic<br>*Distinct cell borders<br>*Atypical nuclei with perinuclear halo | ||
|} | |} |
Revision as of 17:07, 31 July 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Renal cell carcinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Renal cell carcinoma other diagnostic studies On the Web |
American Roentgen Ray Society Images of Renal cell carcinoma other diagnostic studies |
Risk calculators and risk factors for Renal cell carcinoma other diagnostic studies |
Overview
A needle biopsy should always be performed when the finding of a renal mass is detected on imaging.
Needle Biopsy
Needle biopsy should always be performed when the finding of a renal mass is detected on imaging. CT or MRI guided needle biopsy distinguishes between different subgroups of renal cell carcinoma and identifies management: active surveillance, surgery, or medical therapy.[1] The sensitivity and specificity of needle biopsy are very high. The rate of biopsy-related complications, including biopsy-associated seeding, is considered very low.[1]
Type | Characteristic Features |
Conventional (Clear Cell) | *Nests of tumor cells that are compacted near each other *Clear cytoplasm *Delicate vasculature that separates the cytoplasm *Varying architectural patterns, such as solid, alveolar, or acinar |
Papillary | *Papillae, tubulopapillae, and tubules that are present in differing percentages *Type I generally has papillae lined with only 1 layer of cancer cells, pale cytoplasm, and small oval nuclei *Type II generally are more heterogeneous tumors that have pseudostratification with large, spherical nuclei and distinct nucleoli |
Chromophobe | *Large polygonal cells *Finely reticulated cytoplasm that may be eosinophilic *Distinct cell borders *Atypical nuclei with perinuclear halo |
References
- ↑ 1.0 1.1 Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH; et al. (2013). "Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline". J Urol. 190 (2): 407–16. doi:10.1016/j.juro.2013.04.121. PMID 23665399.
- ↑ Cohen HT, McGovern FJ (2005). "Renal-cell carcinoma". N Engl J Med. 353 (23): 2477–90. doi:10.1056/NEJMra043172. PMID 16339096.
- ↑ Rini BI, Campbell SC, Escudier B (2009). "Renal cell carcinoma". Lancet. 373 (9669): 1119–32. doi:10.1016/S0140-6736(09)60229-4. PMID 19269025.